Isabel Caragol

2.1k total citations
34 papers, 696 citations indexed

About

Isabel Caragol is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Isabel Caragol has authored 34 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Immunology and 10 papers in Virology. Recurrent topics in Isabel Caragol's work include HIV Research and Treatment (10 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Cytomegalovirus and herpesvirus research (6 papers). Isabel Caragol is often cited by papers focused on HIV Research and Treatment (10 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Cytomegalovirus and herpesvirus research (6 papers). Isabel Caragol collaborates with scholars based in Spain, United States and Romania. Isabel Caragol's co-authors include Teresa Español, M. Hernández, Pere Soler‐Palacín, Martin Catala, Claire Fieschi, J. Feinberg, Jean‐Laurent Casanova, Nieves Larrosa, Concepció Figueras and Òscar Asensio and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Nature reviews. Immunology.

In The Last Decade

Isabel Caragol

34 papers receiving 672 citations

Peers

Isabel Caragol
Jose Rivera United States
Daniel A. Ozaki United States
S. Blanche France
Michelle L. Paulson United States
Shelley Segal United Kingdom
M. Garcia-Lloret United States
M. G. Hammond South Africa
Juana Gil Spain
Jose Rivera United States
Isabel Caragol
Citations per year, relative to Isabel Caragol Isabel Caragol (= 1×) peers Jose Rivera

Countries citing papers authored by Isabel Caragol

Since Specialization
Citations

This map shows the geographic impact of Isabel Caragol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Caragol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Caragol more than expected).

Fields of papers citing papers by Isabel Caragol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Caragol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Caragol. The network helps show where Isabel Caragol may publish in the future.

Co-authorship network of co-authors of Isabel Caragol

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Caragol. A scholar is included among the top collaborators of Isabel Caragol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Caragol. Isabel Caragol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caragol, Isabel, Carmen Alonso, Teresa Ramón y Cajal, et al.. (2014). Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism. APOPTOSIS. 20(3). 371–382. 18 indexed citations
2.
Hennig, Christian, Kaan Boztuǧ, Julia Skokowa, et al.. (2013). High-content cytometry and transcriptomic biomarker profiling of human B-cell activation. Journal of Allergy and Clinical Immunology. 133(1). 172–180.e10. 12 indexed citations
3.
Martín‐Nalda, Andrea, Lino Marques, Pere Soler‐Palacín, et al.. (2009). VISCERAL LEISHMANIASIS ASSOCIATED HEMOPHAGOCYTIC SYNDROME IN PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE. The Pediatric Infectious Disease Journal. 28(8). 753–754. 24 indexed citations
4.
Soler‐Palacín, Pere, et al.. (2008). Common variable immunodeficiency: 20‐yr experience at a single centre. Pediatric Allergy and Immunology. 20(2). 113–118. 27 indexed citations
5.
Crespo, Manuel, et al.. (2008). Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAART. Enfermedades Infecciosas y Microbiología Clínica. 26(1). 27–31. 4 indexed citations
6.
Detková, Drahomíra, Javier de Gracia, Susana L. Silva, et al.. (2007). Common Variable Immunodeficiency. CHEST Journal. 131(6). 1883–1889. 36 indexed citations
7.
Soler‐Palacín, Pere, et al.. (2007). Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergologia et Immunopathologia. 35(3). 83–89. 63 indexed citations
8.
Español, Teresa, Isabel Caragol, Pere Soler Masó, & M. Hernández. (2004). Pediatric HIV Infection.. PubMed. 3(4). 159–63. 2 indexed citations
9.
Caragol, Isabel, Miquel Raspall‐Chaure, Claire Fieschi, et al.. (2003). Clinical Tuberculosis in 2 of 3 Siblings with Interleukin-12 Receptor  1 Deficiency. Clinical Infectious Diseases. 37(2). 302–306. 93 indexed citations
10.
Calle-Martin, Oscar De La, M. Hernández, Natàlia Casamitjana, et al.. (2001). Familial CD8 deficiency due to a mutation in the CD8α gene. Journal of Clinical Investigation. 108(1). 117–123. 58 indexed citations
11.
Allende, Luís M., M. Hernández, Alfredo Corell, et al.. (2000). A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/lymphocyte function‐associated antigen‐1 functional association in humans. Immunology. 99(3). 440–450. 17 indexed citations
12.
Barretina, Jordi, Julià Blanco, Arantxa Gutiérrez, et al.. (2000). Evaluation of the putative role of C‐C chemokines as protective factors of HIV‐1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives. Transfusion. 40(4). 461–467. 11 indexed citations
13.
López, Antonio, Isabel Caragol, Neus Villamor, et al.. (1999). Enumeration of CD4+ T-cells in the peripheral blood of HIV-infected patients: An interlaboratory study of the FACSCount system. Cytometry. 38(5). 231–237. 29 indexed citations
14.
Más, Antonio, Teresa Español, Alonso Heredia, et al.. (1999). CCR5 genotype and HIV-1 infection in perinatally-exposed infants. Journal of Infection. 38(1). 9–11. 12 indexed citations
15.
Coll, O., M. Hernández, Charles A. Boucher, et al.. (1997). Vertical HIV-1 Transmission Correlates with a High Maternal Viral Load at Delivery. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(1). 26–30. 48 indexed citations
16.
Noé, Verónique, Chao Chen, Marta Nicolàs, et al.. (1997). Cell‐Growth Regulation of the Hamster Dihydrofolate Reductase Gene Promoter by Transcription Factor Sp1. European Journal of Biochemistry. 249(1). 13–20. 24 indexed citations
17.
Albanell, Joan, J Bellmunt, Raquel Molina, et al.. (1996). Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis.. PubMed. 16(2). 1027–32. 40 indexed citations
18.
Balsells, Joaquín, Isabel Caragol, Elena Allende, et al.. (1996). DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver. Journal of Hepatology. 25(6). 854–858. 9 indexed citations
19.
Español, Teresa, et al.. (1994). Evolution of immunological abnormalities in HIV infection by vertical transmission. Acta Paediatrica. 83(s400). 35–38. 4 indexed citations
20.
Español, Teresa, et al.. (1991). Immunological Abnormalities in Pediatric Aids. Immunological Investigations. 20(2). 215–221. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026